...
首页> 外文期刊>Indian journal of pharmacology. >Evaluation of Cynanchum otophyllum glucan sulfate against human immunodeficiency virus and herpes simplex virus as a microbicide agent.
【24h】

Evaluation of Cynanchum otophyllum glucan sulfate against human immunodeficiency virus and herpes simplex virus as a microbicide agent.

机译:评价Cynanchum otophyllum葡聚糖硫酸盐作为杀微生物剂对抗人免疫缺陷病毒和单纯疱疹病毒。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: The root of Cynanchum otophyllum-also known as Qing Yang Sheng-is a traditional ethnical Chinese medicine. The objective of this study was to evaluate in vitro activities and safety of C. otophyllum glucan sulfate (PS20) against Human Immunodeficiency Virus (HIV) and Herpes Simplex Virus (HSV). MATERIALS AND METHODS: Anti-HIV activity was detected with syncytial formation assay and quantitative P24 Enzyme-Linked Immunosorbent Assay (ELISA). Anti-HSV activity was detected with plaque reduction assay; cytotoxicity was tested with MTT colorimetric assay; and anti-bacterial activity was tested with microdilution method. Anti-HIV mechanism was investigated with fusion inhibition, time of addition, and pretreatment. RESULTS: The 50% Inhibition Concentration (IC(50)) of PS20 for HIV-1(IIIB), HIV-(Ada-M), HIV-1(Bal), HSV-I, and -II were 0.26 +/- 0.02 mM, 0.46 +/- 0.02 mM, 0.90 +/- 0.04 mM, 3.45 +/- 0.85 muM, and 0.70 +/- 0.22 mM, respectively. Selectivity Indices (SI) were 653, 50, 39, 85, and 362, respectively. Studies on anti-HIV mechanism of PS20 showed that the target molecule should be the envelope protein. The 50% Cytotoxicity Concentrations (CC(50)) of PS20 for HeLa and ME-180 cell lines and human foreskin fibroblast cells was more than 70 muM. The Minimum Inhibitory Concentration (MIC) for vaginal lactobacilli was more than 1000 muM. CONCLUSION: PS20 possesses anti-HIV and HSV effect and low cytotoxicity to epithelium cells and vaginal lactobacilli. It may be considered as a potential microbicide agent for further investigation.
机译:目的:耳兰的根是传统的民族中药。这项研究的目的是评估硫酸耳蜗葡聚糖葡聚糖(PS20)对抗人类免疫缺陷病毒(HIV)和单纯疱疹病毒(HSV)的体外活性和安全性。材料与方法:通过合胞体形成测定和定量P24酶联免疫吸附测定(ELISA)检测抗HIV活性。用噬斑减少试验检测抗HSV活性。用MTT比色法检测细胞毒性。微量稀释法检测其抗菌活性。通过融合抑制,添加时间和预处理研究了抗HIV机制。结果:PS20对HIV-1(IIIB),HIV-(Ada-M),HIV-1(Bal),HSV-I和-II的50%抑制浓度(IC(50))为0.26 +/-分别为0.02 mM,0.46 +/- 0.02 mM,0.90 +/- 0.04 mM,3.45 +/- 0.85μM和0.70 +/- 0.22 mM。选择性指数(SI)分别为653、50、39、85和362。 PS20的抗HIV机制研究表明目标分子应该是包膜蛋白。 PS20对HeLa和ME-180细胞系以及人包皮成纤维细胞的50%细胞毒性浓度(CC(50))超过70μM。阴道乳酸菌的最低抑菌浓度(MIC)超过1000μM。结论:PS20具有抗HIV和HSV作用,对上皮细胞和阴道乳杆菌的细胞毒性低。它可能被认为是潜在的杀菌剂,需要进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号